ArticleArthritis research & therapy2026

Allogeneic CD19 CAR-NK cell therapy for a patient with relapsed and refractory lupus nephritis.

Yu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.